search
Back to results

Trimodal Prehabilitation in Pancreatic Cancer Patients Urdergoing Neoadjuvant Treatment (PREPANC)

Primary Purpose

Pancreatic Neoplasms

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Trimodal prehabilitation
Sponsored by
Puerta de Hierro University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Pancreatic Neoplasms focused on measuring exercise, pancreatic, cancer, trimodal

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: More than 18 years old ECOG 0-2 Being able to complete the mile-time test Stages I-III Being able to understand the informed consent Pancreatic cancer diagnosed Exclusion Criteria: Metastasic cancer

Sites / Locations

  • Hospital Universitario Puerta de Hierro MajadahondaRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Training group

Arm Description

Pancreatic patients will participate in the trimodal prehabilitation: nutrition, psychological and exercise support.

Outcomes

Primary Outcome Measures

To explore the feasibility of a trimodal prehabilitation program in the hospital setting
Adherence to 70% of supervised physical exercise sessions and to nutrition and psychologist sessions

Secondary Outcome Measures

Changes in (estimated) cardiorespiratory fitness
Mile-time test
Changes in muscle strength
Handgrip by dynamometry
Changes in body mass index
BMI (Body Mass Index kg/sm)
Changes in body composition
waist, hip, calf circumferences
Changes in levels of physical activity at week
Accelerometry
Changes in quality of life
EORTC-QLQ-C30 (European Organization for Research and Treatment of Cancer. Quality of Life questionnaire. C30. all scores of the QLQ-C30 were transformed linearly so that all scales ranged from 0 to 100. In the function scales higher scores represent a better level of functioning while in the case of symptom scales/items higher scores mark a higher level of symptomatology or problems.
Describe changes in fatigue levels
PERFORM (Multidimensional scale 12-60. The higher the less fatigue)
Dose intensity in neoadjuvant treatment
percentage of intended doses that are administered in the due time
Describe post-surgical complications
Surgical wound and pancreatic fistula
Nutritional status
body mass index
Percentage of pathological complete responses
Percentage of patients with no viable cells in the surgical specimen
Percentage of patients receiving adjuvant therapy
Patients that received at least two cycles after surgery
Hindrances and facilitators of patients
Qualitative methods. semi-structured interviews and observation
Anxiety and depression
HADS questionnaire. Values 8-21. The higher the worse

Full Information

First Posted
March 14, 2022
Last Updated
January 31, 2023
Sponsor
Puerta de Hierro University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05722223
Brief Title
Trimodal Prehabilitation in Pancreatic Cancer Patients Urdergoing Neoadjuvant Treatment
Acronym
PREPANC
Official Title
Trimodal Prehabilitation in Pancreatic Cancer Patients Candidate to Neoadjuvant Treatment: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 15, 2022 (Actual)
Primary Completion Date
March 15, 2023 (Anticipated)
Study Completion Date
December 20, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Puerta de Hierro University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Pancreatic cancer is a disease with a very poor prognosis and less than 10% of these patients live beyond 5 years from diagnosis. Further, it is expected to become the second leading cause of death in the coming years. Today, surgery remains the cornerstone in curing this disease, but the addition of chemotherapy is needed to improve survival. The impact of adjuvant treatment has been previously demonstrated and its efficacy is absolute. However, neoadjuvant chemotherapy (pre-surgery) improves the results after surgery (achieving earlier stages and with better prognosis) and would lead to better survival results. Besides, the moment of cancer diagnosis is a moment of special receptivity to change lifestyles ("teachable moment"). Multimodal prehabilitation includes 1) physical exercise; 2) nutritional and 3) psychological support. The potential advantages of prehabilitation during neoadjuvant therapy would be 1) the possibility of achieving a better physical condition to face surgery; 2) fewer postoperative complications; 3) more likely to receive adjuvant treatment after surgery; 4) better physical function at the end of treatments. To date, most studies have focused on lung and prostate cancer, with a high prevalence of men in the series. This strategy has previously been explored, showing that it is safe and feasible, (Loughney et al). We have not identified any study of trimodal prehabilitation during neoadjuvant treatment and none that has integrated motivational strategies to maintain adherence. Patients during chemotherapy have perceived several adverse effects that could limit adherence to the program. In this regard, a review on the motivation and exercise in cancer survivors shows that it is necessary to apply theoretical frameworks to understand cognitive and motivational processes and develop educational interventions. The self-determination theory (SDT, Deci and Ryan) is one of the motivational theories most applied today to the analysis of factors related to the adoption of healthy lifestyles. Likewise, patients who are motivated are more likely to improve healthy habits and obtain greater adherence to exercise performance. Therefore, we aimed of carrying out an intervention (pilot study) in ten patients to describe the feasibility of a trimodal prehabilitation program in the hospital environment, applying motivational strategies and a mixed-method (face-to-face and online).
Detailed Description
outcome measures refer to feasibility of the intervention: Recruitment Attendance to the training sessions Attendance to psychologist and nutritionist sessions And also to physical condition Cardiorespiratory fitness Muscular strength Body composition Physical activity Quality of life Fatigue score

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatic Neoplasms
Keywords
exercise, pancreatic, cancer, trimodal

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
All the participants will receive trimodal prehabilitation. Only one arm
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Training group
Arm Type
Experimental
Arm Description
Pancreatic patients will participate in the trimodal prehabilitation: nutrition, psychological and exercise support.
Intervention Type
Combination Product
Intervention Name(s)
Trimodal prehabilitation
Intervention Description
Pancreatic cancer patients (not stage 4) will undergo trimodal prehabilitation: nutrition, psychological, and exercise support.
Primary Outcome Measure Information:
Title
To explore the feasibility of a trimodal prehabilitation program in the hospital setting
Description
Adherence to 70% of supervised physical exercise sessions and to nutrition and psychologist sessions
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Changes in (estimated) cardiorespiratory fitness
Description
Mile-time test
Time Frame
3-6 months (from 1st treatment to surgery)
Title
Changes in muscle strength
Description
Handgrip by dynamometry
Time Frame
3-6 months (from 1st treatment to surgery)
Title
Changes in body mass index
Description
BMI (Body Mass Index kg/sm)
Time Frame
3-6 months (from 1st treatment to surgery)
Title
Changes in body composition
Description
waist, hip, calf circumferences
Time Frame
3-6 months (from 1st treatment to surgery)
Title
Changes in levels of physical activity at week
Description
Accelerometry
Time Frame
3-6 months (from 1st treatment to surgery)
Title
Changes in quality of life
Description
EORTC-QLQ-C30 (European Organization for Research and Treatment of Cancer. Quality of Life questionnaire. C30. all scores of the QLQ-C30 were transformed linearly so that all scales ranged from 0 to 100. In the function scales higher scores represent a better level of functioning while in the case of symptom scales/items higher scores mark a higher level of symptomatology or problems.
Time Frame
3-6 months (from before1st treatment to surgery)
Title
Describe changes in fatigue levels
Description
PERFORM (Multidimensional scale 12-60. The higher the less fatigue)
Time Frame
3-6 months (from before 1st treatment to surgery)
Title
Dose intensity in neoadjuvant treatment
Description
percentage of intended doses that are administered in the due time
Time Frame
3-6 months (from 1st treatment to surgery)
Title
Describe post-surgical complications
Description
Surgical wound and pancreatic fistula
Time Frame
three months
Title
Nutritional status
Description
body mass index
Time Frame
3-6 months (from 1st treatment to surgery)
Title
Percentage of pathological complete responses
Description
Percentage of patients with no viable cells in the surgical specimen
Time Frame
4-6 weeks after surgery
Title
Percentage of patients receiving adjuvant therapy
Description
Patients that received at least two cycles after surgery
Time Frame
Three months after surgery
Title
Hindrances and facilitators of patients
Description
Qualitative methods. semi-structured interviews and observation
Time Frame
During the prehabilitation program (3-6 months for each patient)
Title
Anxiety and depression
Description
HADS questionnaire. Values 8-21. The higher the worse
Time Frame
3-6 months (from 1st treatment to surgery)
Other Pre-specified Outcome Measures:
Title
Circulating tumor DNA and mutational variations
Description
circulant tumor DNA
Time Frame
before initiating chemotherapy

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: More than 18 years old ECOG 0-2 Being able to complete the mile-time test Stages I-III Being able to understand the informed consent Pancreatic cancer diagnosed Exclusion Criteria: Metastasic cancer
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ana Ruiz-Casado, MD
Phone
607890187
Email
arcasado@salud.madrid.org
First Name & Middle Initial & Last Name or Official Title & Degree
María Romero Elías, MsC
Phone
611443864
Email
remaria17@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ana Ruiz-Casado, MD
Organizational Affiliation
HU Puerta de Hierro Majadahonda
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Universitario Puerta de Hierro Majadahonda
City
Majadahonda
State/Province
Madrid
ZIP/Postal Code
28222
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maria Romero Elias, PhD
Email
remaria17@gmail.com
First Name & Middle Initial & Last Name & Degree
Ana Ruiz Casado, MD PhD
Email
arcasado@salud.madrid.org

12. IPD Sharing Statement

Citations:
PubMed Identifier
30880749
Citation
Alejo LB, Pagola-Aldazabal I, Fiuza-Luces C, Huerga D, de Torres MV, Verdugo AS, Ortega Solano MJ, Felipe JL, Lucia A, Ruiz-Casado A. Exercise prehabilitation program for patients under neoadjuvant treatment for rectal cancer: A pilot study. J Cancer Res Ther. 2019 Jan-Mar;15(1):20-25. doi: 10.4103/jcrt.JCRT_30_17.
Results Reference
background
PubMed Identifier
31232076
Citation
Ausania F, Senra P, Melendez R, Caballeiro R, Ouvina R, Casal-Nunez E. Prehabilitation in patients undergoing pancreaticoduodenectomy: a randomized controlled trial. Rev Esp Enferm Dig. 2019 Aug;111(8):603-608. doi: 10.17235/reed.2019.6182/2019.
Results Reference
background
PubMed Identifier
28489682
Citation
Barberan-Garcia A, Ubre M, Roca J, Lacy AM, Burgos F, Risco R, Momblan D, Balust J, Blanco I, Martinez-Palli G. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg. 2018 Jan;267(1):50-56. doi: 10.1097/SLA.0000000000002293.
Results Reference
background
PubMed Identifier
29219922
Citation
Bolshinsky V, Li MH, Ismail H, Burbury K, Riedel B, Heriot A. Multimodal Prehabilitation Programs as a Bundle of Care in Gastrointestinal Cancer Surgery: A Systematic Review. Dis Colon Rectum. 2018 Jan;61(1):124-138. doi: 10.1097/DCR.0000000000000987.
Results Reference
background
PubMed Identifier
32826168
Citation
Bundred JR, Kamarajah SK, Hammond JS, Wilson CH, Prentis J, Pandanaboyana S. Prehabilitation prior to surgery for pancreatic cancer: A systematic review. Pancreatology. 2020 Sep;20(6):1243-1250. doi: 10.1016/j.pan.2020.07.411. Epub 2020 Aug 3.
Results Reference
background
PubMed Identifier
27913000
Citation
Carli F, Silver JK, Feldman LS, McKee A, Gilman S, Gillis C, Scheede-Bergdahl C, Gamsa A, Stout N, Hirsch B. Surgical Prehabilitation in Patients with Cancer: State-of-the-Science and Recommendations for Future Research from a Panel of Subject Matter Experts. Phys Med Rehabil Clin N Am. 2017 Feb;28(1):49-64. doi: 10.1016/j.pmr.2016.09.002.
Results Reference
background
PubMed Identifier
23458160
Citation
Chandrabalan VV, McMillan DC, Carter R, Kinsella J, McKay CJ, Carter CR, Dickson EJ. Pre-operative cardiopulmonary exercise testing predicts adverse post-operative events and non-progression to adjuvant therapy after major pancreatic surgery. HPB (Oxford). 2013 Nov;15(11):899-907. doi: 10.1111/hpb.12060. Epub 2013 Feb 20.
Results Reference
background
PubMed Identifier
20194863
Citation
Djarv T, Metcalfe C, Avery KN, Lagergren P, Blazeby JM. Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer. J Clin Oncol. 2010 Apr 1;28(10):1666-70. doi: 10.1200/JCO.2009.23.5143. Epub 2010 Mar 1.
Results Reference
background
PubMed Identifier
31562341
Citation
Florez Bedoya CA, Cardoso ACF, Parker N, Ngo-Huang A, Petzel MQ, Kim MP, Fogelman D, Romero SG, Wang H, Park M, Katz MHG, Schadler KL. Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients. Sci Rep. 2019 Sep 27;9(1):13966. doi: 10.1038/s41598-019-49582-3.
Results Reference
background
Citation
González-Cutre D, Sicilia A, Sierra AC et al. Understanding the need for novelty from the perspective of self-determination theory. Personality and Individual Differences 2016; 102:159-169
Results Reference
background
PubMed Identifier
31900809
Citation
Gruber ES, Jomrich G, Kaider A, Gnant M, Sahora K, Schindl M. The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. Ann Surg Oncol. 2020 Jun;27(6):2017-2024. doi: 10.1245/s10434-019-08161-6. Epub 2020 Jan 3. Erratum In: Ann Surg Oncol. 2020 Dec;27(Suppl 3):985.
Results Reference
background
PubMed Identifier
22673593
Citation
Jie B, Jiang ZM, Nolan MT, Zhu SN, Yu K, Kondrup J. Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk. Nutrition. 2012 Oct;28(10):1022-7. doi: 10.1016/j.nut.2012.01.017. Epub 2012 Jun 5.
Results Reference
background
PubMed Identifier
17582629
Citation
Jones LW, Peddle CJ, Eves ND, Haykowsky MJ, Courneya KS, Mackey JR, Joy AA, Kumar V, Winton TW, Reiman T. Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions. Cancer. 2007 Aug 1;110(3):590-8. doi: 10.1002/cncr.22830.
Results Reference
background
PubMed Identifier
18672211
Citation
Jones LW, Eves ND, Haykowsky M, Joy AA, Douglas PS. Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol. 2008 Aug;9(8):757-65. doi: 10.1016/S1470-2045(08)70195-5.
Results Reference
background
PubMed Identifier
19454641
Citation
Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, Sugawara A, Totsuka K, Shimano H, Ohashi Y, Yamada N, Sone H. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009 May 20;301(19):2024-35. doi: 10.1001/jama.2009.681.
Results Reference
background
PubMed Identifier
24938279
Citation
Kokkinos P, Faselis C, Myers J, Sui X, Zhang J, Blair SN. Age-specific exercise capacity threshold for mortality risk assessment in male veterans. Circulation. 2014 Aug 19;130(8):653-8. doi: 10.1161/CIRCULATIONAHA.114.009666. Epub 2014 Jun 17.
Results Reference
background
PubMed Identifier
30473464
Citation
Kurita Y, Kobayashi N, Tokuhisa M, Goto A, Kubota K, Endo I, Nakajima A, Ichikawa Y. Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy. Pancreatology. 2019 Jan;19(1):127-135. doi: 10.1016/j.pan.2018.11.001. Epub 2018 Nov 10.
Results Reference
background
PubMed Identifier
29377872
Citation
Lee CHA, Kong JC, Ismail H, Riedel B, Heriot A. Systematic Review and Meta-analysis of Objective Assessment of Physical Fitness in Patients Undergoing Colorectal Cancer Surgery. Dis Colon Rectum. 2018 Mar;61(3):400-409. doi: 10.1097/DCR.0000000000001017.
Results Reference
background
PubMed Identifier
28097305
Citation
Ljungqvist O, Scott M, Fearon KC. Enhanced Recovery After Surgery: A Review. JAMA Surg. 2017 Mar 1;152(3):292-298. doi: 10.1001/jamasurg.2016.4952.
Results Reference
background
PubMed Identifier
34158253
Citation
Morielli AR, Usmani N, Boule NG, Severin D, Tankel K, Joseph K, Nijjar T, Fairchild A, Courneya KS. Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial. Clin Colorectal Cancer. 2021 Sep;20(3):216-226. doi: 10.1016/j.clcc.2021.05.004. Epub 2021 May 26.
Results Reference
background
PubMed Identifier
33422020
Citation
O'Connor D, Brown M, Eatock M, Turkington RC, Prue G. Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: a systematic review. BMC Cancer. 2021 Jan 9;21(1):43. doi: 10.1186/s12885-020-07733-0.
Results Reference
background
PubMed Identifier
27881567
Citation
Ross R, Blair SN, Arena R, Church TS, Despres JP, Franklin BA, Haskell WL, Kaminsky LA, Levine BD, Lavie CJ, Myers J, Niebauer J, Sallis R, Sawada SS, Sui X, Wisloff U; American Heart Association Physical Activity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Cardiovascular and Stroke Nursing; Council on Functional Genomics and Translational Biology; Stroke Council. Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association. Circulation. 2016 Dec 13;134(24):e653-e699. doi: 10.1161/CIR.0000000000000461. Epub 2016 Nov 21.
Results Reference
background
PubMed Identifier
11392867
Citation
Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000 Jan;55(1):68-78. doi: 10.1037//0003-066x.55.1.68.
Results Reference
background
PubMed Identifier
25788991
Citation
Smith HR. Depression in cancer patients: Pathogenesis, implications and treatment (Review). Oncol Lett. 2015 Apr;9(4):1509-1514. doi: 10.3892/ol.2015.2944. Epub 2015 Feb 9.
Results Reference
background
PubMed Identifier
19604193
Citation
Smith TB, Stonell C, Purkayastha S, Paraskevas P. Cardiopulmonary exercise testing as a risk assessment method in non cardio-pulmonary surgery: a systematic review. Anaesthesia. 2009 Aug;64(8):883-93. doi: 10.1111/j.1365-2044.2009.05983.x.
Results Reference
background
PubMed Identifier
26879805
Citation
Spencer JC, Wheeler SB. A systematic review of Motivational Interviewing interventions in cancer patients and survivors. Patient Educ Couns. 2016 Jul;99(7):1099-1105. doi: 10.1016/j.pec.2016.02.003. Epub 2016 Feb 8.
Results Reference
background
PubMed Identifier
29330843
Citation
Tew GA, Ayyash R, Durrand J, Danjoux GR. Clinical guideline and recommendations on pre-operative exercise training in patients awaiting major non-cardiac surgery. Anaesthesia. 2018 Jun;73(6):750-768. doi: 10.1111/anae.14177. Epub 2018 Jan 13.
Results Reference
background
PubMed Identifier
25869228
Citation
Tsimopoulou I, Pasquali S, Howard R, Desai A, Gourevitch D, Tolosa I, Vohra R. Psychological Prehabilitation Before Cancer Surgery: A Systematic Review. Ann Surg Oncol. 2015 Dec;22(13):4117-23. doi: 10.1245/s10434-015-4550-z. Epub 2015 Apr 14.
Results Reference
background

Learn more about this trial

Trimodal Prehabilitation in Pancreatic Cancer Patients Urdergoing Neoadjuvant Treatment

We'll reach out to this number within 24 hrs